LBL-003 / Leads Biolabs 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LBL-003 / Leads Biolabs
NCT05042908: Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies

Completed
1
18
RoW
LBL-003 Injection, LBL-003
Nanjing Leads Biolabs Co.,Ltd, Henan Cancer Hospital, Hunan Cancer Hospital, Shandong Cancer Hospital and Institute
Advanced Malignant Tumor
04/23
04/23

Download Options